These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 38091232)

  • 21. Endothelial dysfunction in diabetes mellitus.
    Hadi HA; Suwaidi JA
    Vasc Health Risk Manag; 2007; 3(6):853-76. PubMed ID: 18200806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-155 in the pathogenesis of atherosclerosis: a conflicting role?
    Ma X; Ma C; Zheng X
    Heart Lung Circ; 2013 Oct; 22(10):811-8. PubMed ID: 23827206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetically altered macrophages promote development of diabetes-associated atherosclerosis.
    Huang D; Gao W; Zhong X; Wu H; Zhou Y; Ma Y; Qian J; Ge J
    Front Immunol; 2023; 14():1196704. PubMed ID: 37215106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxia inducible factor as a therapeutic target for atherosclerosis.
    Jain T; Nikolopoulou EA; Xu Q; Qu A
    Pharmacol Ther; 2018 Mar; 183():22-33. PubMed ID: 28942242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2013 Russell Ross memorial lecture in vascular biology: cellular and molecular mechanisms of diabetes mellitus-accelerated atherosclerosis.
    Bornfeldt KE
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):705-14. PubMed ID: 24665124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PKCδ regulates the vascular biology in diabetic atherosclerosis.
    Qin P; He C; Ye P; Li Q; Cai C; Li Y
    Cell Commun Signal; 2023 Nov; 21(1):330. PubMed ID: 37974282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct effects of glucose and glucosamine on vascular endothelial and smooth muscle cells: evidence for a protective role for glucosamine in atherosclerosis.
    Duan W; Paka L; Pillarisetti S
    Cardiovasc Diabetol; 2005 Oct; 4():16. PubMed ID: 16207378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Research advance in the effects of androgen and its receptor on the development of obesity, obesity-related diseases and disorders of glucose and lipid metabolism].
    Yin LJ; Wang XH
    Sheng Li Xue Bao; 2018 Jun; 70(3):319-328. PubMed ID: 29926074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009.
    DeFronzo RA
    Diabetologia; 2010 Jul; 53(7):1270-87. PubMed ID: 20361178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-blockers for Atherosclerosis Prevention: a Missed Opportunity?
    Vrablik M; Corsini A; Tůmová E
    Curr Atheroscler Rep; 2022 Mar; 24(3):161-169. PubMed ID: 35174437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current views on neuropeptide Y and diabetes-related atherosclerosis.
    Sun WW; Zhu P; Shi YC; Zhang CL; Huang XF; Liang SY; Song ZY; Lin S
    Diab Vasc Dis Res; 2017 Jul; 14(4):277-284. PubMed ID: 28423914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From Diabetes to Atherosclerosis: Potential of Metformin for Management of Cardiovascular Disease.
    Poznyak AV; Litvinova L; Poggio P; Moschetta D; Sukhorukov VN; Orekhov AN
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD36 in Atherosclerosis: Pathophysiological Mechanisms and Therapeutic Implications.
    Tian K; Xu Y; Sahebkar A; Xu S
    Curr Atheroscler Rep; 2020 Aug; 22(10):59. PubMed ID: 32772254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipophagy in atherosclerosis.
    Liu Q; Wang YM; Gu HF
    Clin Chim Acta; 2020 Dec; 511():208-214. PubMed ID: 33096029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dyslipidemia Part 1--Review of Lipid Metabolism and Vascular Cell Physiology.
    Helkin A; Stein JJ; Lin S; Siddiqui S; Maier KG; Gahtan V
    Vasc Endovascular Surg; 2016 Feb; 50(2):107-18. PubMed ID: 26983667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
    Cersosimo E; DeFronzo RA
    Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hippo: A New Hub for Atherosclerotic Disease.
    Liu XY; Zhou K; Tian KJ; Yan BJ; Ren Z; Zhou ZX; Xiong WH; Jiang ZS
    Curr Pharm Des; 2022; 28(16):1321-1328. PubMed ID: 35974674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-coding RNAs in cardiovascular cell biology and atherosclerosis.
    Fasolo F; Di Gregoli K; Maegdefessel L; Johnson JL
    Cardiovasc Res; 2019 Oct; 115(12):1732-1756. PubMed ID: 31389987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Large Extracellular Vesicle-Associated Rap1 Accumulates in Atherosclerotic Plaques, Correlates With Vascular Risks and Is Involved in Atherosclerosis.
    Perdomo L; Vidal-Gómez X; Soleti R; Vergori L; Duluc L; Chwastyniak M; Bisserier M; Le Lay S; Villard A; Simard G; Meilhac O; Lezoualc'h F; Khantalin I; Veerapen R; Dubois S; Boursier J; Henni S; Gagnadoux F; Pinet F; Andriantsitohaina R; Martínez MC;
    Circ Res; 2020 Aug; 127(6):747-760. PubMed ID: 32539601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p38 mitogen-activated protein kinase: a critical node linking insulin resistance and cardiovascular diseases in type 2 diabetes mellitus.
    Liu Z; Cao W
    Endocr Metab Immune Disord Drug Targets; 2009 Mar; 9(1):38-46. PubMed ID: 19275680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.